Retatrutide

99.6 % purity , research use only not for human use or veterinary.

Retatrutide (development code LY3437943) is an investigational synthetic peptide, classified as a triple metabolic receptor agonist. It is the subject of ongoing global research exploring how simultaneous activation of three key biological pathways — GLP‑1, GIP, and glucagon receptors — influences metabolic function.

Research findings indicate it MAY:

• Support balanced glucose regulation by enhancing insulin release in response to nutrients and moderating hepatic glucose output

• Increase resting energy expenditure and promote efficient fat metabolism, including reduction of excess stored fat in tissues such as the liver

• Modulate signals of satiety and gastric emptying, helping to regulate eating patterns and nutrient absorption

• Help preserve lean tissue while altering how the body utilises and stores energy

• Improve markers of metabolic health, including liver function and inflammatory balance, in study models

Research into this compound is still ongoing, with studies continuing to assess long‑term effects, safety profiles, and potential applications in understanding metabolic health. This product is provided exclusively for laboratory and educational research purposes, and is not approved or intended for human therapeutic use please do your own research Sealed, & shipped professionally